Outcome Assessment Under Suspected Treatment Differences

Why Assessment Can Become an Operational Bias Pathway

A treatment difference may be suspected before a trial ends, even when outcome assessors remain formally masked to allocation. A participant’s comments, a treatment-related symptom, or information conveyed during routine contact can shape an assessor’s belief about which treatment the participant received or how well it is working. The assessor may then make slightly different judgments when applying a rating scale, deciding whether an event meets a definition, or determining whether an outcome can be recorded.

These decisions matter because the recorded endpoint is what enters the analysis. Randomization balances treatment groups at allocation; it does not guarantee that post-allocation measurement, event classification, or missingness decisions are made identically. The concern is not that an assessor must intentionally favor a treatment. Small, unconscious differences in applying a threshold can produce differential measurement.

The distinction between \(Y\) and \(Y^*\) is conceptual: an underlying clinical state may not be directly observable, especially for pain, function, symptom severity, or event attribution. The goal is not to claim that every endpoint has a perfectly observable “true” value. It is to recognize that recorded values can depend on judgment, and to make the judgment process as consistent and independent as possible.

How Ratings and Classifications Can Differ

For a binary endpoint, define sensitivity as the probability that an assessor records a positive endpoint when the underlying endpoint is positive, and specificity as the probability of recording a negative endpoint when it is negative. If \(p\) is the underlying positive proportion, \(Se\) is sensitivity, and \(Sp\) is specificity, the expected recorded positive proportion is

The first term counts correctly recorded positives; the second counts false positives. If \(Se\) or \(Sp\) differs between arms, equal underlying proportions need not produce equal recorded proportions. This is one reason that randomization alone does not protect a subjective endpoint from differential assessment.

The same issue arises when assessors classify whether a clinical event meets a protocol definition, assign severity, or attribute an event to a category. A threshold can be applied differently without changing the event itself. For ordinal scales, a shift in how borderline cases are rated can move observations between adjacent categories and affect the estimated treatment contrast.

Missingness Is Also an Assessment Decision

An endpoint can be missing because an assessment was not attempted, a response was judged uninterpretable, a record was considered insufficient, or a participant could not be reached. Some reasons are outside an assessor’s control. Others involve judgment, such as whether a borderline response is usable. If such decisions depend on treatment beliefs and are also related to the outcome, comparing only recorded outcomes can distort the treatment contrast.

For a binary endpoint, let \(m_1\) be the probability that an outcome is missing among participants whose underlying outcome is positive, and \(m_0\) the corresponding probability among those whose outcome is negative. If the underlying positive proportion is \(p\), the positive proportion among those with recorded outcomes is

The numerator is the probability of being positive and recorded. The denominator is the probability of being recorded, including both positive and negative outcomes. Unless missingness is unrelated to outcome within the group, the recorded participants need not have the same outcome distribution as all randomized participants. If the missingness process differs between arms, this selection can differ between arms as well.

Practical Safeguards and Diagnostics

Safeguards should make the assessment process reproducible and reduce opportunities for beliefs about treatment differences to influence judgment. The appropriate combination depends on how subjective the endpoint is, how often it is measured, and whether independent review is feasible.

• Specify operational definitions before assessment. Define rating anchors, event criteria, allowable source information, assessment windows, and what qualifies as an unevaluable outcome. Give assessors concrete rules for borderline cases.
• Use standardized, neutral prompts. Provide the same questions and instructions across arms, avoid leading language, and record the participant’s response before any interpretation where feasible.
• Separate assessment from comparative information. Assessors should not receive interim arm-level outcome summaries or informal interpretations of treatment differences. Necessary role and information boundaries should be established and followed.
• Use independent review for consequential subjective endpoints. A trained reviewer or adjudication panel can assess de-identified source material against prespecified criteria. Independence and masking are safeguards, not guarantees: reviewers can still disagree or infer treatment from the record.
• Record reasons for missing or unevaluable outcomes. Use prespecified categories and document the information supporting the decision. Avoid retrospectively changing the definition of an assessable outcome in response to emerging patterns.
• Train and calibrate assessors. Practice cases and periodic review of agreement can expose unclear criteria. Training should emphasize consistent application, not a preferred pattern of results.

Diagnostics can identify patterns that warrant investigation, although no single diagnostic proves that assessment bias occurred or did not occur. Review missingness rates and reasons by arm and assessment time; examine category frequencies and borderline classifications; and compare assessment patterns across sites and assessors. For subjective ratings, duplicate independent ratings on a prespecified subset can reveal disagreement or systematic shifts. When interpreting these checks, consider the possibility that small samples create unstable patterns and that an absence of a visible difference does not establish absence of bias.

If a potential measurement problem is found, preserve the original records and document the review process. A blinded re-review using prespecified criteria can help determine whether classifications are reproducible. For missing outcomes, report the extent and reasons for missingness by group and assess how conclusions change under plausible assumptions about the unobserved values. Statistical sensitivity analyses can show dependence on assumptions, but they cannot recover information that was never collected or prove which missingness assumption is correct.

Choosing Between Prevention and Analytical Adjustment

The main alternative to preventing differential assessment is to model or adjust for measurement error after data collection. Prevention is generally preferable: consistent definitions, independent assessment, and documented decisions address the source of the problem before it enters the analysis. Analytical correction may be useful when validation data or credible information about classification accuracy are available, but it requires additional assumptions. For example, a correction using sensitivity and specificity assumes those quantities are known or estimable and applicable to the trial groups. Uncertainty in those quantities should be reflected in the analysis.

For missing outcomes, complete-case analysis is simple but represents the recorded participants and can be biased when recording depends on outcome. Other methods can use observed information under explicit assumptions, and sensitivity analyses can examine departures from those assumptions. No method should be described as removing bias merely because it produces a numerical estimate. State the assumptions and explain how plausible violations could affect interpretation.

Where possible, an objective endpoint may reduce reliance on judgment, but “objective” does not mean error-free: definitions, timing, equipment, and data processing can still differ. Conversely, a subjective endpoint may be clinically important and cannot always be replaced. The practical aim is consistent measurement, transparent documentation, and conclusions that acknowledge remaining uncertainty.

Common Pitfall

Wrong reasoning: “Allocation was randomized, so any difference in recorded outcomes must reflect a treatment effect.” Randomization supports comparability at assignment; it does not force assessors to use identical thresholds after they form different beliefs, nor does it guarantee equal missingness decisions.

Correction: Ask whether the endpoint was defined and collected in the same way across groups. Distinguish the clinical outcome from its recorded classification, examine assessment and missingness processes by arm, and describe any assumptions needed to interpret the treatment contrast. Also avoid assuming that nondifferential classification error always moves an estimate toward no effect; its direction depends on the endpoint and error structure.